Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


BIOGEN INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Product8,846.9010,692.2011,379.8010,886.8010,354.709,817.909,188.508,203.405,542.304,166.07
Other revenues476.30774.60707.70585.90360.00316.40236.10304.50263.90212.46
Revenue from unconsolidated joint business1,658.501,977.802,290.401,980.201,559.201,314.501,339.201,195.401,126.001,137.92
Corporate partner--------------------
Royalties--------------------
Total Revenues10,981.7013,444.6014,377.9013,452.9012,273.9011,448.8010,763.809,703.306,932.205,516.46
Cost of sales2,109.701,805.201,955.401,816.301,630.001,478.701,240.401,171.00857.70545.49
Cost of royalty revenues--------------------
Cost of product revenues--------------------
Manufacturing costs--------------------
Gross Profit----------------6,074.504,970.97
Amortization of acquired intangible assets881.30464.80489.90747.30814.70385.60382.60489.80342.90202.20
Research and development2,501.203,990.902,280.602,597.202,253.601,973.302,012.801,893.401,444.101,334.92
Acquired in-process research and development18.0075.00--112.50120.00----------
Selling, general and administrative2,674.302,504.502,374.702,106.301,933.901,946.602,113.102,232.301,712.101,277.47
Restructuring charges----1.5012.000.9033.1093.40----2.23
Collaboration profit (loss) sharing(7.20)(232.90)(241.60)(185.00)(112.30)(10.20)----(85.40)(317.90)
(Gain) loss on settlement of license agreements, net--------(62.70)(14.80)------(27.20)
Fair value adjustment of contingent consideration50.7086.3063.7012.30----(30.50)38.900.50--
Gain on sale of rights--------------16.8024.9046.79
Facility impairments and loss on sale--------------------
TECFIDERA litigation settlement charge----------(454.80)--------
Loss on divestiture of Hillerod, Denmark manufacturing operations--92.50(55.30)--------------
Total Cost and Expenses8,141.008,894.507,335.307,564.306,928.106,297.105,872.805,747.704,441.603,707.40
Operating Income (Loss)2,840.704,550.107,042.605,888.605,345.805,151.704,891.003,972.402,515.501,855.85
Interest expense--------------------
Interest income--------------------
Other income (expense), net(1,095.50)497.4083.3011.00(217.00)(218.70)(123.70)(25.80)(34.90)(0.74)
Income (loss) before income taxes (benefit)1,745.205,047.507,125.905,899.605,128.804,933.004,767.303,946.602,480.601,855.11
Deferred------------------(116.90)
Current :Federal------------1,214.10----507.90
Deferred :Foreign------------(14.10)----29.10
Current :State------------38.60----35.60
Deferred :Federal------------(129.60)----(133.00)
Deferred :State------------(1.90)----(13.00)
Current :Foreign------------54.50----44.00
Income taxes (benefit)52.50992.301,158.001,425.602,458.701,237.301,161.60989.90601.00470.55
Current------------------587.50
Equity in loss of investee, net of tax34.905.30(79.40)------(12.50)(15.10)(17.20)(4.52)
Income Before Cumulative Effect Of Accounting Change--------------------
Cumulative effect of accounting change, net of income tax benefit of $487--------------------
Consolidated Net Income (Loss)1,727.604,060.505,888.504,474.002,670.103,695.703,593.202,941.601,862.301,380.03
Net income (loss) attributable to noncontrolling interest, net of tax171.5059.90--43.30131.00(7.10)46.206.80----
Net income attributable to Biogen Idec Inc1,556.104,000.605,888.504,430.702,539.103,702.803,547.002,934.801,862.301,380.03
Before cumulative effect of accounting change--------------------
Cumulative effect of accounting change--------------------
Net Earnings Per Share (Basic)10.4424.8631.4721.6311.9416.9615.3812.427.865.80
Before cumulative effect of accounting change--------------------
Cumulative effect of accounting change--------------------
Net Earnings Per Share (Diluted)10.4024.8031.4221.5811.9216.9315.3412.377.815.76
Weighted Average Shares Outstanding (Basic)149.10160.90187.10204.90212.60218.40230.70236.40236.90237.94
Weighted Average Shares Outstanding (Diluted)149.60161.30187.40205.30213.00218.80231.20237.20238.30239.74